Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merrimack Pharmaceuticals

15.13
0.0000
Volume:- -
Turnover:- -
Market Cap:223.75M
PE:1.08
High:15.13
Open:15.13
Low:15.13
Close:15.13
Loading ...
Sep 19, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Sep 19, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Aug 16, 2019

Correspondence

[Cover]Correspondence
Jul 26, 2019

Major Issues Report

Current report, item 4.01
Jul 25, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jul 24, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jul 18, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 17, 2019

Major Issues Report

Current report, items 4.01 and 9.01
Jul 17, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 12, 2019

Major Issues Report

Current report, item 2.01
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 01, 2019

Major Issues Report

[Amend] Current report, item 2.05
Jul 01, 2019

Major Issues Report

Current report, item 5.02
Jul 01, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Jun 24, 2019

Major Issues Report

Current report, items 1.01 and 9.01
May 30, 2019

Major Issues Report

Current report, items 1.01, 2.05, 5.02, 7.01, and 9.01
May 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 10, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Apr 30, 2019

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]